Francesco Lanza

InstitutionOcular Oncology Center
AddressGenoa
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 3 publications in June 2020
    All Publications
    Bar chart showing 70 publications over 20 distinct years, with a maximum of 9 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Passamonti F, Romano A, Salvini M, Merli F, Porta MGD, Bruna R, Coviello E, Romano I, Cairoli R, Lemoli R, Farina F, Venditti A, Busca A, Ladetto M, Massaia M, Pinto A, Arcaini L, Tafuri A, Marchesi F, Fracchiolla N, Bocchia M, Armiento D, Candoni A, Krampera M, Luppi M, Cardinali V, Galimberti S, Cattaneo C, La Barbera EO, Mina R, Lanza F, Visani G, Musto P, Petrucci L, Zaja F, Grossi PA, Bertù L, Pagano L, Corradini P. COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies. Br J Haematol. 2021 11; 195(3):371-377. PMID: 34272724.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    2. Barcellini W, Fattizzo B, Giannotta JA, Quattrocchi L, Aydin S, Barone F, Carbone C, Pomponi F, Metafuni E, Beggiato E, Sica S, Di Bona E, Lanza F, Notaro R, Iori AP. COVID-19 in patients with paroxysmal nocturnal haemoglobinuria: an Italian multicentre survey. Br J Haematol. 2021 09; 194(5):854-856. PMID: 34036575.
      Citations: 1     Fields:    Translation:Humans
    3. Seidita V, Lanza F, Pipitone A, Chella A. Robots as intelligent assistants to face COVID-19 pandemic. Brief Bioinform. 2021 03 22; 22(2):823-831. PMID: 33326994.
      Citations:    Fields:    Translation:HumansPHPublic Health
    4. Gambacorti-Passerini C, Ruggeri M, Aroldi A, Piazza R, Mazzi A, De Silvestro G, Krampera M, Lanza F. Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies. Transfus Apher Sci. 2021 06; 60(3):103105. PMID: 33637468.
      Citations: 1     Fields:    Translation:Humans
    5. Lanza F, Seghatchian J. Trends and targets of various types of stem cell derived transfusable RBC substitution therapy: Obstacles that need to be converted to opportunity. Transfus Apher Sci. 2020 Oct; 59(5):102941. PMID: 32958397.
      Citations:    Fields:    Translation:HumansCells
    6. Passamonti F, Cattaneo C, Arcaini L, Bruna R, Cavo M, Merli F, Angelucci E, Krampera M, Cairoli R, Della Porta MG, Fracchiolla N, Ladetto M, Gambacorti Passerini C, Salvini M, Marchetti M, Lemoli R, Molteni A, Busca A, Cuneo A, Romano A, Giuliani N, Galimberti S, Corso A, Morotti A, Falini B, Billio A, Gherlinzoni F, Visani G, Tisi MC, Tafuri A, Tosi P, Lanza F, Massaia M, Turrini M, Ferrara F, Gurrieri C, Vallisa D, Martelli M, Derenzini E, Guarini A, Conconi A, Cuccaro A, Cudillo L, Russo D, Ciambelli F, Scattolin AM, Luppi M, Selleri C, Ortu La Barbera E, Ferrandina C, Di Renzo N, Olivieri A, Bocchia M, Gentile M, Marchesi F, Musto P, Federici AB, Candoni A, Venditti A, Fava C, Pinto A, et al. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Lancet Haematol. 2020 Oct; 7(10):e737-e745. PMID: 32798473.
      Citations: 112     Fields:    Translation:HumansCellsPHPublic Health
    7. Lanza F, Seidita V, Chella A. Agents and robots for collaborating and supporting physicians in healthcare scenarios. J Biomed Inform. 2020 08; 108:103483. PMID: 32603793.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    8. Brissot E, Labopin M, Baron F, Bazarbachi A, Bug G, Ciceri F, Esteve J, Giebel S, Gilleece MH, Gorin NC, Lanza F, Peric Z, Ruggeri A, Sanz J, Savani BN, Schmid C, Shouval R, Spyridonidis A, Versluis J, Nagler A, Mohty M. Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2021 03; 56(3):532-535. PMID: 32528122.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    9. Lanza F, Seghatchian J. Reflection on passive immunotherapy in those who need most: some novel strategic arguments for obtaining safer therapeutic plasma or autologous antibodies from recovered COVID-19 infected patients. Br J Haematol. 2020 Jul; 190(1):e27-e29. PMID: 32407543.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health